The chemical class termed UGT2A3 Activators encompasses a diverse group of compounds known to influence the expression and activity of the UDP-glucuronosyltransferase (UGT) family of enzymes, to which UGT2A3 belongs. These activators are not a homogeneous group but are rather characterized by their ability to interact with various cellular signaling pathways and transcription factors that regulate the expression and function of UGT2A3. The understanding of these activators comes from the study of molecular biology and pharmacogenomics, where the expression of drug-metabolizing enzymes is known to be modulated by endogenous and exogenous signals. These signals can elicit a cascade of intracellular events, leading to altered transcription and translation of enzymes like UGT2A3.
Activators in this category can operate through several mechanisms. For example, some compounds can bind to nuclear receptors, which then translocate to the nucleus and bind to specific DNA sequences, initiating transcription of genes, including those encoding UGTs. Other activators work by inducing the stabilization and nuclear translocation of transcription factors, such as Nrf2, which then binds to antioxidant response elements in the promoters of target genes. Additionally, activators may function by modulating the activity of existing enzymes or altering the processing and degradation of the enzyme, thereby affecting the overall metabolic capacity of the cell. Through these complex and interrelated pathways, activators can upregulate the expression of UGT2A3, impacting its availability and activity within the cell. The study of these activators provides insight into the regulation of metabolic pathways responsible for the detoxification and elimination of various substrates, contributing to our understanding of metabolic homeostasis and the broader responses of cells to chemical exposures.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $95.00 $322.00 $663.00 $1438.00 | 6 | |
Rifampicin has the potential to induce UGT enzymes by acting as an agonist for the PXR, which could upregulate UGT2A3 expression. | ||||||
Oltipraz | 64224-21-1 | sc-205777 sc-205777A | 500 mg 1 g | $286.00 $622.00 | ||
Oltipraz can activate Nrf2, a transcription factor that could result in the increased expression of detoxification enzymes, including UGT2A3. | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $32.00 | ||
Clofibrate can activate PPARs, which may lead to an upregulation of UGT enzymes as part of the body's response to altered lipid metabolism, possibly affecting UGT2A3. | ||||||
Chrysin | 480-40-0 | sc-204686 | 1 g | $37.00 | 13 | |
Chrysin, a flavonoid, can modulate various receptors and transcription factors that could possibly activate UGT2A3 by enhancing its expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol has been shown to modulate several signaling pathways and could possibly activate UGT2A3 through its action on sirtuins and other factors. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $150.00 $286.00 $479.00 $1299.00 $8299.00 $915.00 | 22 | |
Sulforaphane can activate Nrf2, which could lead to a potential increase in UGT2A3 expression as part of the antioxidant response. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Dexamethasone can induce certain UGT enzymes by activating the glucocorticoid receptor, which could possibly activate UGT2A3. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin can modulate a variety of cellular pathways, and could possibly activate UGT2A3 through its interaction with transcription factors. | ||||||
Piperine | 94-62-2 | sc-205809 sc-205809A | 5 g 25 g | $36.00 $143.00 | 3 | |
Piperine can enhance the bioavailability of various compounds and has been reported to influence the expression of drug-metabolizing enzymes, which could include UGT2A3. | ||||||
Andrographolide | 5508-58-7 | sc-205594 sc-205594A | 50 mg 100 mg | $15.00 $39.00 | 7 | |
Andrographolide, a diterpenoid compound, has been observed to modulate anti-inflammatory and detoxification pathways, which could possibly activate UGT2A3. | ||||||